CLX // Clorox Company (The)

DES <GO> NYSE CIK 0000021076 ↗

Consumer Discretionary • Specialty Chemicals

$88.67 ▲ +1.83 (+2.11%)

MKT CAP: $10.72B • VOL: 3.68M

52W L $79 52W H $129

ALTMAN Z

2.93 GREY

PIOTROSKI

7 / 9

CLX // ROARABLE RATING & 5-PILLAR RQD CONFIDENCE 02:00 EST DETERMINISTIC ENGINE

▼ DOWNGRADE // C+ (RQD 66) -> C (RQD 65) AS OF 2026-11-01

ROARABLE C

RQD CONFIDENCE

65 / 100 -1D

5 X 20-PT QUANT PILLARS

E 0 D 35 C 59 B 70 A 86+

Roarable Hold — Fair / Balanced Risk-Reward

01 MASSIVE / SEC XBRL

Forensic Fundamentals

15 / 20

SOLID

FCF +57.6% vs NI +182.2% • ROIC-WACC +29.7% • Z 2.93

02 OPRA GEX + SEC 13F

Whale & Options Flow

[LOCKED] FLAGGED

UNLOCK BELOW TO REVEAL

03 SEC FORM 4 (90D)

Insider Conviction

[LOCKED] FLAGGED

UNLOCK BELOW TO REVEAL

04 FRED 90D r-MATRIX

Macro Regime Fit

13 / 20

SOLID

TAILWIND • r(10Y)=+0.00 (+23bp) • r(OAS)=+0.00

05 10-K REDLINE AUDIT

Forensic 10-K Risk

15 / 20

SOLID

20 BASE - 5 DEDUCT • 0 CRIT / 0 MED • STABLE

ALERT

Why did CLX's Whale & Options Flow & Insider Conviction sub-score just flash a warning? Enter your email to unlock the full 5-Pillar Rating Breakdown + get instant alerts whenever CLX is Upgraded or Downgraded.

SIG <GO> CROSS-FEED TRIANGULATION // PROPRIETARY ANOMALY ENGINE (1 ACTIVE ON CLX)

STAGE 2 DETERMINISTIC Z-SCORE + STAGE 3 GEEK DESK BRIEF ALL MARKET ANOMALIES <SIG>

▼ BEARISH // F-RATED EARNINGS MIRAGE // ACCRUAL WATCHSIFTER 02 // ACCRUAL & RECEIVABLES FORENSICS

SEVERITY: 83/100 Z-SCORE: +2.46σ

CLX Accounting Gap: Net Income (+182.2%) Outpaced OCF (+41.2%) With +11.7% Working-Capital Build

CASH CONVERSION GAP

+141.0% (NI vs OCF)

RECEIVABLES / WC BLOAT

+11.7% VS REV

60D C-SUITE FORM 4 SALES

0 OPEN-MKT DUMPS

[GEEK DESK FORENSIC NOTE // SEC XBRL × FORM 4 CROSS-CHECK]

SEC EDGAR XBRL CompanyFacts10-K/10-Q Working Capital ScheduleSEC Form 4 Executive Sales

SEC EDGAR XBRL triangulation on Clorox Company (The) (CLX) exposes a +141.0% Cash Conversion Gap as YoY Net Income growth (+182.2%) diverged from Operating Cash Flow growth (+41.2%). Non-cash current assets and receivables expanded +11.7% relative to top-line revenue growth. Monitor upcoming 10-Q cash realization closely for accrual mean-reversion.

CLX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -8.75%📐 HORIZONTAL RANGE

2026-10-30O $90.02H $90.78L $87.44C $88.00VOL 3.87M

RES: $117.6SUP: $74.38SMA50: $88.60SMA200: $99.77

CLX // INSTITUTIONAL BULL VS. BEAR FORENSIC DEBATE

ACCUMULATE CONVICTION: 65/100

BEAR 0

100 BULL

Clorox Company (The) (CLX) exhibits 45.2% gross margins and 37.2% return on invested capital within Consumer Discretionary (Specialty Chemicals), balanced against a 10.9x enterprise multiple and 6.7% implied options volatility.

▲ INSTITUTIONAL BULL THESIS (LONG)

01. Operating Leverage & Capital Efficiency Moat

Sustained 45.2% gross profitability converts into 14.2% operating margin and 37.2% ROIC, outpacing sector cost of capital.

ROIC: 37.2% // GM: 45.2%

02. Top-Line Expansion & Cash Conversion

YoY revenue trajectory of +0.2% paired with 7.10% free cash flow yield supports self-funded R&D and capital return.

REV YOY: +0.2% // FCF YLD: 7.10%

03. Balance Sheet Solvency & Forensic Quality

Altman Z-Score of 2.93 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.

ALTMAN Z: 2.93 // F-SCORE: 7/9

▼ INSTITUTIONAL BEAR THESIS (SHORT / RISK)

01. Multiple Compression & Duration Sensitivity

Trading at 13.0x trailing P/E (12.1x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.

P/E: 13.0x // EV/EBITDA: 10.9x

02. Options Skew & Event Volatility Risk

Options market prices a ±6.7% implied move with a 0.68 put/call ratio around $87.00 max pain.

IMPL MOVE: ±6.7% // P/C: 0.68

03. Competitive Margin & CapEx Cycle Pressure

Elevated industry capital intensity and customer concentration in Specialty Chemicals require continuous execution to defend 11.6% net margins.

NET MARGIN: 11.6% // D/E: 0.85x

KEY CATALYST // Upcoming 10-Q/10-K XBRL margin progression, guidance revision vs 12.1x forward consensus, and institutional 13F positioning.

MACRO REGIME // Monitor US 10Y Real Yields (DFII10) and High-Yield Credit Spreads (OAS) for beta-adjusted multiple impact (Beta 0.93).

FORM 4 & 13F FLOW OPEN OWN <GO>

FILER	SIDE	$ VALUE
INSPECT FULL OWNERSHIP LEDGER IN OWN <GO>

UNUSUAL OPTIONS TAPE OPEN OPT <GO>

STRIKE / EXP	TYPE	PREMIUM
INSPECT GEX & CHAIN IN OPT <GO>

KEY VALUATION & PROFITABILITY RATIOS XBRL FA <GO>

TRAILING P/E 13.0x

FORWARD P/E 12.1x

EV / EBITDA 10.9x

FCF YIELD 7.10%

GROSS MARGIN 45.2%

OPERATING MARGIN 14.2%

NET MARGIN 11.6%

ROIC % 37.2%

REV GROWTH YOY +0.2%

DILUTED EPS TTM $6.81

DEBT / EQUITY 0.85x

DIVIDEND YIELD 5.61%

RSI-14 MOMENTUM 53.8

5Y EQUITY BETA 0.93

FRED MACRO SENSITIVITY (PEARSON r) ECST <GO>

MACRO CORRELATION CALIBRATION ACTIVE BELOW.

FRED MACRO REGIME STRESS-TEST SIMULATOR // CLXPEARSON R VARIANCE ENGINE

01 // SELECT FEDERAL RESERVE & CREDIT SHOCK SCENARIO

02 // POSITION NOTIONAL EXPOSURE

HEADLINE STRESS SCORE

75/100SEVERE DRAWDOWN PRESSURE

PRIMARY FACTOR EXPOSURE

DFII10 // -0.61 r

Latest: 2.08%

EST. DIRECTIONAL MOVE

-8.50%

Implied Px: $81.14

EST. DOLLAR VARIANCE

-$4,248

On $50,000 Notional

[LOCKED // MULTI-FACTOR DRAWDOWN HEDGE & MACRO TRIGGER ALERT]

Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CLX & activate live FRED threshold breach alerts.

HEAD-TO-HEAD PEER COMPARISONS COMP <GO>

CLX VS AMZN

MARGINS ROIC VALUATION

CLX VS TSLA

MARGINS ROIC VALUATION

CLX VS V

MARGINS ROIC VALUATION

CLX VS MA

MARGINS ROIC VALUATION